medicinePoliticsThe Bleach Community Is Ready for RFK Jr. to Make Their Dreams Come TrueBy David GilbertGearWhat Are Exosomes, and Why Are They in Your Skin Care?By Boutayna Chokrane ScienceWhy Women With Type 2 Diabetes Are Diagnosed Later Than MenBy Lori YoumshajekianScienceA Baby Received a Custom Crispr Treatment in Record TimeBy Emily MullinBusinessBlocked From Selling Off-Brand Ozempic, Telehealth Startups Embrace a Less Effective DrugBy Kate KnibbsSciencePatients Are Left With Few Options as GLP-1 Copycats DisappearBy Emily Mullin and Kate KnibbsScienceDiabetes Is Rising in Africa. Could It Lead to New Breakthroughs?By David CoxBusinessOpenAI and the FDA Are Holding Talks About Using AI In Drug EvaluationBy Zoë Schiffer, Emily Mullin, and Will KnightScienceHHS Orders Lab Studying Deadly Infectious Diseases to Stop ResearchBy Emily MullinBusinessEli Lilly Sues 4 GLP-1 Telehealth Startups, Escalating War on Knockoff DrugsBy Kate Knibbs and Emily MullinBusinessThousands of Urine and Tissue Samples Are in Danger of Rotting After Staff Cuts at a CDC LaboratoryBy Caroline HaskinsScienceAn Experimental Obesity Pill Mimics Gastric Bypass SurgeryBy Emily MullinScienceDoctor Behind Award-Winning Parkinson’s Research Among Scientists Purged From NIHBy Dell Cameron and Emily MullinGearWhat Are Those Weird Devices Basketball Players Are Holding?By Ben DowsettScienceYour Love Life on OzempicBy Emily MullinThe Big StoryThe King of Ozempic Is Scared as HellBy Virginia HeffernanScienceThese Newly Identified Cells Could Change the Face of Plastic SurgeryBy Max G. LevyScienceThere’s Still Time to Get Ahead of the Next Global PandemicBy Caitlin RiversScienceThe World’s First Crispr Drug Gets a Slow StartBy Emily MullinScienceA Mysterious Respiratory Disease Has the Democratic Republic of the Congo on High AlertBy Marta MussoBusinessMark Cuban’s War on Drug Prices: ‘How Much Fucking Money Do I Need?’By Marah EakinScienceThese Stem Cell Treatments Are Worth Millions. Donors Get Paid $200By Matt ReynoldsScienceWhy an Offline Nuclear Reactor Led to Thousands of Hospital Appointments Being CanceledBy Chris BaraniukScienceNeuralink Plans to Test Whether Its Brain Implant Can Control a Robotic ArmBy Emily MullinMore Stories
